Several potential risks arise from concurrent cannabis and Wegovy use, though robust clinical trial data specifically examining this combination are currently unavailable: Reduced treatment efficacy : The most significant concern is that cannabis-induced appetite stimulation may counteract Wegovy's appetite-suppressing effects, potentially compromising weight loss outcomes
Currently, intense media attention and influencer promotion, coupled with robust marketing tactics, have led to an increase in the demand for GLP-1 RAs, resulting in global shortages of these medications
Recent studies have also indicated a significant association between NAION and diabetes, which may exacerbate vascular dysregulation
These softer options may feel more manageable: Soft scrambled eggs Plain Greek yogurt Cottage cheese Shredded chicken in broth Flaky baked white fish Silken tofu cubes High protein shakes For more ideas, see Getting Enough Protein
Patients can benefit from medically assisted weight loss without the need for invasive surgeries or harsh stimulants
